GSK And Google To Invest £540m In UK-Headquartered Bioelectronics JV

GlaxoSmithKline is teaming up with the company formerly known as Google Life Sciences to create bioelectronic therapeutics, and hopes to have a product ready for market within seven years.

More from Business

More from Scrip